Your browser doesn't support javascript.
loading
Treatment Inequity: Examining the Influence of Non-Hispanic Black Race and Ethnicity on Pancreatic Cancer Care and Survival in Wisconsin.
Schiefelbein, Andrea M; Krebsbach, John K; Taylor, Amy K; Zhang, Jienian; Haimson, Chloe E; Trentham-Dietz, Amy; Skala, Melissa C; Eason, John M; Weber, Sharon M; Varley, Patrick R; Zafar, Syed N; LoConte, Noelle K.
Afiliação
  • Schiefelbein AM; Morgridge Institute for Research, Madison, Wisconsin.
  • Krebsbach JK; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Taylor AK; Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison Wisconsin.
  • Zhang J; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Haimson CE; Department of Sociology, University of Wisconsin-Madison, Madison, Wisconsin.
  • Trentham-Dietz A; Department of Sociology, University of Wisconsin-Madison, Madison, Wisconsin.
  • Skala MC; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Eason JM; Department of Population Health Sciences, University of Wisconsin-Madison, Madison, Wisconsin.
  • Weber SM; Morgridge Institute for Research, Madison, Wisconsin.
  • Varley PR; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.
  • Zafar SN; Department of Biomedical Engineering, University of Wisconsin-Madison, Madison, Wisconsin.
  • LoConte NK; Department of Sociology, University of Wisconsin-Madison, Madison, Wisconsin.
WMJ ; 121(2): 77-93, 2022 Jul.
Article em En | MEDLINE | ID: mdl-35857681
INTRODUCTION: We investigated race and ethnicity-based disparities in first course treatment and overall survival among Wisconsin pancreatic cancer patients. METHODS: We identified adults diagnosed with pancreatic adenocarcinoma in the Wisconsin Cancer Reporting System from 2004 through 2017. We assessed race and ethnicity-based disparities in first course of treatment via adjusted logistic regression and overall survival via 4 incremental Cox proportional hazards regression models. RESULTS: The study included 8,490 patients: 91.3% (n = 7,755) non-Hispanic White; 5.1% (n = 437) non-Hispanic Black, 1.8% (n = 151) Hispanic, 0.6% Native American (n = 53), and 0.6% Asian (n = 51) race and ethnicities. Non-Hispanic Black patients had lower odds of treatment than non-Hispanic White patients for full patient (OR, 0.52; 95% CI, 0.41-0.65) and Medicare cohorts (OR, 0.40; 95% CI, 0.29-0.55). Non-Hispanic Black patients had lower odds of receiving surgery than non-Hispanic White patients (full cohort OR, 0.67 [95% CI, 0.48-0.92]; Medicare cohort OR, 0.57 [95% CI, 0.34-0.93]). Non-Hispanic Black patients experienced worse survival than non-Hispanic White patients in the first 2 incremental Cox proportional hazard regression models (model II HR, 1.18; 95% CI, 1.06-1.31). After adding insurance and treatment course, non-Hispanic Black and non-Hispanic White patients experienced similar survival (HR, 0.98; 95% CI, 0.88-1.09). CONCLUSION: Non-Hispanic Black patients were almost 50% less likely to receive any treatment and 33% less likely to receive surgery than non-Hispanic White patients. After including treatment course, non-Hispanic Black and non-Hispanic White patient survival was similar. Increasing non-Hispanic Black patient treatment rates by addressing structural factors affecting treatment availability and employing culturally humble approaches to treatment discussions may mitigate these disparities.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / População Negra / Disparidades em Assistência à Saúde Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Adenocarcinoma / População Negra / Disparidades em Assistência à Saúde Idioma: En Ano de publicação: 2022 Tipo de documento: Article